health.ec.europa.eu
- Domain
- health.ec.europa.eu
- Category
- Uncategorized
- Publisher
- europa.eu
Top References from health.ec.europa.eu
| Score | Article | Date | Citations |
|---|---|---|---|
| 3.0 |
Attitudes of Europeans towards tobacco and electronic cigarettes - Public Healthhttps://health.ec.europa.eu/publications/attitudes-europeans-towards-tobacco-and-electronic-cigarettes-1_en |
N/A | 1 |
| 3.0 |
Health Threat Prioritisation Assessment strengthens Europe’s preparedness - Public Healthhttps://health.ec.europa.eu/latest-updates/health-threat-prioritisation-assessment-strengthens-europes-preparedness-2026-01-09_en |
N/A | 1 |
| 3.0 |
Guidance on reporting requirements for multiplicity issues and subgroup, sensitivity and post hoc analyses in joint clinical assessments - Public Healthhttps://health.ec.europa.eu/publications/guidance-reporting-requirements-multiplicity-issues-and-subgroup-sensitivity-and-post-hoc-analyses_en |
N/A | 1 |
| 3.0 |
Tissues and cellshttps://health.ec.europa.eu/blood-tissues-cells-and-organs/tissues-and-cells_en |
N/A | 1 |
| 3.0 |
DIRECTIVE 2014/40/EU OF THE EUROPEAN PARLIAMENT AND OF THE COUNCILhttps://health.ec.europa.eu/system/files/2016-11/dir_201440_en_0.pdf |
N/A | 1 |
| 3.0 |
Product regulation - Public Health - European Commissionhttps://health.ec.europa.eu/tobacco/product-regulation_en |
N/A | 1 |
| 3.0 |
Guidance on outcomes for joint clinical assessments - Public Healthhttps://health.ec.europa.eu/publications/guidance-outcomes-joint-clinical-assessments_en |
N/A | 1 |
| 3.0 |
SCCS Scientific Opinion on Hydroxyapatite (nano) – Submission IVhttps://health.ec.europa.eu/publications/sccs-scientific-opinion-hydroxyapatite-nano-submission-iv_en |
N/A | 1 |
| 3.0 |
Guidance - MDCG endorsed documents and other guidance - European Commissionhttps://health.ec.europa.eu/medical-devices-sector/new-regulations/guidance-mdcg-endorsed-documents-and-other-guidance_en |
N/A | 1 |
| 3.0 |
Guidance on the validity of clinical studies for joint clinical assessments - Public Healthhttps://health.ec.europa.eu/publications/guidance-validity-clinical-studies-joint-clinical-assessments_en |
N/A | 1 |
| 3.0 |
Practical Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons - Public Healthhttps://health.ec.europa.eu/publications/practical-guideline-quantitative-evidence-synthesis-direct-and-indirect-comparisons_en |
N/A | 1 |
| 3.0 |
New Regulations - European Commissionhttps://health.ec.europa.eu/medical-devices-sector/new-regulations_en |
N/A | 1 |
| 3.0 |
Methodological Guideline for Quantitative Evidence Synthesis: Direct and Indirect Comparisons - Public Healthhttps://health.ec.europa.eu/publications/methodological-guideline-quantitative-evidence-synthesis-direct-and-indirect-comparisons_en |
N/A | 1 |
| 3.0 |
4-Methylbenzylidene camphor (4-MBC) - European Commissionhttps://health.ec.europa.eu/publications/4-methylbenzylidene-camphor-4-mbc_en |
N/A | 1 |